Globus Medical (GMED) Finished Goods (2018 - 2025)

Globus Medical's Finished Goods history runs 8 years deep, the most recent figure standing at $555.7 million for Q3 2025.

• Quarterly Finished Goods changed 0.46% year-over-year to $555.7 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $555.7 million (changed 0.46% YoY) and the FY2024 annual result came in at $491.5 million, down 30.53% from the prior year.
• Finished Goods was $555.7 million for Q3 2025 at Globus Medical, roughly flat from $558.4 million in the prior quarter.
• Across five years, Finished Goods topped out at $769.7 million in Q3 2023 and bottomed at $172.1 million in Q3 2021.
• A 5-year average of $390.0 million and a median of $237.4 million in 2023 frame the typical range for Finished Goods.
• Annual changes were most pronounced in 2023 — Finished Goods jumped 273.12% — and 2024, when it slumped 30.53%.
• Globus Medical's Finished Goods stood at $177.8 million in 2021, then climbed by 23.72% to $220.0 million in 2022, then jumped by 221.64% to $707.5 million in 2023, then slumped by 30.53% to $491.5 million in 2024, then climbed by 13.08% to $555.7 million in 2025.
• Business Quant data shows GMED's Finished Goods at $555.7 million in Q3 2025, $558.4 million in Q2 2025, and $497.0 million in Q1 2025.